Sensei Biotherapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| VANGUARD GROUP INC | 05/09/2025 | 585.58 K | $230.72 K | -1.49% | 2.32% |
| IKARIAN CAPITAL, LLC | 05/15/2025 | 449.96 K | $177.29 K | -30.77% | 1.79% |
| CATALIO CAPITAL MANAGEMENT, LP | 05/15/2025 | 294.37 K | $115.98 K | 0.00% | 1.17% |
| RENAISSANCE TECHNOLOGIES LLC | 05/14/2025 | 177.30 K | $69.86 K | 13.07% | 0.70% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/13/2025 | 150.71 K | $59.39 K | 1.22% | 0.60% |
| BOOTHBAY FUND MANAGEMENT, LLC | 05/15/2025 | 108.66 K | $42.81 K | -37.12% | 0.43% |
| UBS GROUP AG | 05/13/2025 | 42.54 K | $16.76 K | 2,126,950.00% | 0.17% |
| NORTHERN TRUST CORP | 05/13/2025 | 25.98 K | $10.24 K | 0.00% | 0.10% |
| STATE STREET CORP | 05/15/2025 | 25.77 K | $10.16 K | 0.00% | 0.10% |
| CRESSET ASSET MANAGEMENT, LLC | 05/13/2025 | 19.67 K | $7.75 K | 0.00% | 0.08% |
| RAYMOND JAMES FINANCIAL INC | 05/13/2025 | 14.00 K | $5.52 K | 0.00% | 0.06% |
| MORGAN STANLEY | 05/15/2025 | 9.22 K | $3.63 K | 0.00% | 0.04% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 05/15/2025 | 5.40 K | $2.13 K | -0.81% | 0.02% |
| BARCLAYS PLC | 05/15/2025 | 2.56 K | $1.00 K | 100.00% | 0.01% |
| JPMORGAN CHASE & CO | 05/12/2025 | 702 | $276 | -0.43% | 0.00% |
| BNP PARIBAS ARBITRAGE, SNC | 05/14/2025 | 160 | $63 | 0.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 05/15/2025 | 142 | $56 | 4.41% | 0.00% |
| CITIGROUP INC | 05/12/2025 | 124 | $49 | 100.00% | 0.00% |
| SBI SECURITIES CO., LTD. | 05/02/2025 | 92 | $36 | 29.58% | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 05/15/2025 | 0 | $0 | -100.00% | 0.00% |
| CITADEL ADVISORS LLC | 05/15/2025 | 0 | $0 | -100.00% | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/14/2025 | 0 | $0 | -100.00% | 0.00% |
| HRT FINANCIAL LP | 05/15/2025 | 0 | $0 | -100.00% | 0.00% |
| XTX TOPCO LTD | 05/08/2025 | 0 | $0 | -100.00% | 0.00% |
| DEUTERIUM CAPITAL MANAGEMENT, LLC | 05/08/2025 | 0 | $0 | -100.00% | 0.00% |
| NWF ADVISORY SERVICES INC. | 08/12/2025 | 0 | $0 | -100.00% | 0.00% |
Sensei Biotherapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 4 institutional investors and hedge funds held shares of Sensei Biotherapeutics, Inc.. The most heavily invested institutionals were:
RAYMOND JAMES & ASSOCIATES: 20,000
BlackRock Inc.: 7,777
LEO BROKERAGE, LLC: 14,845
Amalgamated Financial Corp.: 2,516
7.59% of Sensei Biotherapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 45.14 K shares in the last 24 months. This purchase volume represents approximately $438.74 K in transactions.